Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine in Non-specific Low Back Pain
NCT07737158Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Sep 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Randomised trial of venlafaxine in non-specific low back pain (NSLBP) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Change From Baseline in Average Low Back Pain Intensity at 3 months. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
venlafaxine
03
Conditions
non-specific low back pain (NSLBP)
Beyond the preview
Go deeper on NCT07737158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07737158.